PerkinElmer is currently looking for
R&D Scientist with Bioaffinity Assay expertise
The Turku Site, with 550 employees, represents one of PerkinElmer’s major manufacturing and product development sites for newborn- and maternal fetal health screening. As the global market leader in newborn screening, our solutions have tested over 560 million babies worldwide for life-threatening diseases.
What we offer:
This position is permanent. Please apply by November 18th, 2018. For further information, please contact Teemu Korpimäki by e-mail email@example.com, or by telephone +358 40 3507 398 on Monday, November 5th between 13 – 15, or on Friday, November 9th between 9 – 11.
PerkinElmer Turku Site is a drug free site and a medical examination for new employees includes a drug test.
With 11,000 employees serving over 150 countries, PerkinElmer is a global leader committed to innovating for a healthier world. We are passionate about providing customers with an unmatched experience as they help solve critical issues, especially impacting the diagnostics, and discovery and analytical solutions markets. Our innovative detection, imaging, informatics and service capabilities, combined with deep market knowledge and expertise, help customers gain earlier and more accurate insights to improve lives and the world around us. Join us to make a difference today!